Sacral Nerve Stimulation Devices Market Report 2026

Sacral Nerve Stimulation Devices Market Overview

• Sacral Nerve Stimulation Devices market size has reached to $1.48 billion in 2025 • Expected to grow to $2.54 billion in 2030 at a compound annual growth rate (CAGR) of 11.4% • Growth Driver: Rising Prevalence Of Urological Disorders Drives Sacral Nerve Stimulation Device Market Growth • Market Trend: Innovative Recharge-Free Neuromodulation Systems Enhance Patient Convenience And Therapy Adherence • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Sacral Nerve Stimulation Devices Market?

A sacral nerve stimulation device is a medical implant that uses electrical impulses to modulate nerves in the sacral area. It's used to treat conditions such as urinary incontinence and an overactive bladder by regulating nerve activity. This technology aims to improve bladder function and quality of life for patients through targeted neurological intervention. The main types of sacral nerve stimulation devices are electrical muscle stimulation devices and transcutaneous electrical nerve stimulation (TENS). An electrical muscle stimulation device is a gadget that sends electrical impulses to muscles through electrodes placed on the skin. The various products include external sacral nerve stimulation devices and implantable sacral nerve stimulation devices used for varying ages, such as pediatrics, adults, and geriatrics. It is used for different applications, such as urinary incontinence, fecal incontinence, and others, by hospitals, ambulatory surgical centers, and specialty clinics.

What Is The Sacral Nerve Stimulation Devices Market Growth Forecast?

The sacral nerve stimulation devices market size is expected to see rapid growth in the next few years. It will grow to $2.54 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to increasing adoption of smart implantable devices, rising demand for long-term continence management, expansion of outpatient neuromodulation procedures, growing focus on personalized neurological therapies, increasing investments in bioelectronic medicine. Major trends in the forecast period include increasing adoption of implantable neuromodulation devices, rising demand for minimally invasive bladder control treatments, growing integration of programmable stimulation technologies, expansion of long-term neurological therapy solutions, enhanced focus on patient-specific therapy customization.

Global Sacral Nerve Stimulation Devices Market Segmentation

1) By Technology Modality: Implantable Sacral Neuromodulation, External Sacral Neuromodulation 2) By Product: External Sacral Nerve Stimulation Devices, Implantable Sacral Nerve Stimulation Devices 3) By Age Group: Pediatrics, Adults, Geriatrics 4) By Application: Urinary Incontinence, Fecal Incontinence, Bowel Dysfunction, Other Applications 5) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics Subsegments: 1) By Implantable Sacral Neuromodulation: Rechargeable Implantable SNS Systems, Non-Rechargeable Implantable SNS Systems 2) By External Sacral Neuromodulation: Transcutaneous Sacral Neuromodulation Systems, Wearable External Neuromodulation Devices

What Is The Driver Of The Sacral Nerve Stimulation Devices Market?

The increasing prevalence of urological disorders is expected to propel the growth of the sacral nerve stimulation devices market going forward. Urologic disorders encompass a range of conditions affecting the urinary tract, kidneys, bladder, and prostate, varying in duration from acute to chronic. Urological disorders can arise from various causes, affecting the urinary tract and the reproductive organs. Additionally, lifestyle factors such as poor diet, dehydration, and lack of exercise, can contribute to the development of kidney stones, a painful condition affecting the urinary tract. Sacral nerve stimulation devices provide a minimally invasive treatment option that can effectively manage urological disorders such as urinary and fecal incontinence. For instance, in April 2024, according to the National Institute of Diabetes and Digestive and Kidney Diseases, a US-based healthcare company, on average each year, 651,446 individuals aged 65 and older (212,875 men and 438,572 women) were newly diagnosed with any form of urinary incontinence. Therefore, the increasing prevalence of urological disorders will drive the growth of the sacral nerve stimulation devices industry.

Key Players In The Global Sacral Nerve Stimulation Devices Market

Major companies operating in the sacral nerve stimulation devices market are Abbott, Medtronic plc, Boston Scientific Corporation, Axonics Modulation Technologies, Laborie Medical Technologies, Beijing PINS Medical Co. Ltd., Neuspera Medical, Coloplast Group, Medtronic Neurovascular, NeuroPace Inc., Aleva Neurotherapeutics, LivaNova Neuromodulation, Nalu Medical, SetPoint Medical, NeuroSigma Inc., Saluda Medical, Soterix Medical, Inspire Medical Systems Inc., Synapse Biomedical Inc., Bioinduction Ltd

Global Sacral Nerve Stimulation Devices Market Trends and Insights

Major companies operating in the Sacral Nerve Stimulation (SNS) devices market are focusing on developing innovative solutions, such as recharge-free sacral neuromodulation systems, to enhance patient convenience and therapy adherence. Recharge-free sacral neuromodulation systems are implantable devices that stimulate the sacral nerves to treat bladder and bowel dysfunction without requiring regular battery recharging. For instance, in January 2025, Medtronic PLC, an Ireland-based medical technology company, received FDA approval for the InterStim X Sacral Neuromodulation (SNM) system in India for treating bladder and bowel control issues, including overactive bladder (OAB), chronic fecal incontinence (FI), and non-obstructive urinary retention. These systems feature a proprietary fifth-generation battery providing over 10 years of therapy without recharging, extending up to 15 years on low-energy settings. It includes a smart programmer resembling a smartphone that enables patients to independently adjust up to 11 therapy settings discreetly at home or on the go. Additionally, the system supports SureScan MRI technology, allowing patients to safely undergo full-body 1.5T and 3T MRI scans, with MRI mode easily controlled by the patient under physician guidance.

What Are Latest Mergers And Acquisitions In The Sacral Nerve Stimulation Devices Market?

In January 2024, Boston Scientific Corporation, a US-based biotechnology company, acquired Axonics for $3.7 billion. The acquisition aims to enhance Boston Scientific's medical technology portfolio by incorporating Axonics' differentiated devices for treating urinary and bowel dysfunction. Axonics Inc. is a U.S.-based medical technology company specializing in implantable sacral neuromodulation (SNM) systems for treating urinary urge incontinence and urinary urgency frequency (UUF).

Regional Outlook

North America was the largest region in the sacral nerve stimulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Sacral Nerve Stimulation Devices Market?

The sacral nerve stimulation devices market consists of sales of pulse generators, insulated wires, and electrode arrays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.